| 1 |
Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule：A review[J]. JAMA, 2022, 327(3): 264-273.
|
| 2 |
Liu QX, Zhou D, Han TC, et al. A noninvasive multianalytical approach for lung cancer diagnosis of patients with pulmonary nodules[J]. Adv Sci (Weinh), 2021, 8(13): 2100104.
|
| 3 |
Chen K, Kang G, Zhao H, et al. Liquid biopsy in newly diagnosed patients with locoregional (Ⅰ-ⅢA) non-small cell lung cancer[J]. Expert Rev Mol Diagn, 2019, 19(5): 419-427.
|
| 4 |
Xu K, Zhang C, Du T, et al. Progress of exosomes in the diagnosis and treatment of lung cancer[J]. Biomed Pharmacother, 2021, 134: 111111.
|
| 5 |
Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function？[J]. Genomics Proteomics Bioinformatics, 2015, 13(1): 17-24.
|
| 6 |
Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer[J]. Int J Mol Sci, 2020, 21(5): 1723.
|
| 7 |
ElKashef SMMAE, Ahmad SE, Soliman YMA, et al. Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma[J]. Innate Immun, 2021, 27(1): 61-69.
|
| 8 |
Njock MS, Guiot J, Henket MA, et al. Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis[J]. Thorax, 2019, 74(3): 309-312.
|
| 9 |
Jiang F, Chen Q, Wang W, et al. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1[J]. J Hepatol, 2020, 72(1): 156-166.
|
| 10 |
Ying W, Gao H, Dos Reis FCG, et al. MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice[J]. Cell Metab, 2021, 33(4): 781-790.
|
| 11 |
Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics[J]. Theranostics, 2020, 10(8): 3684-3707.
|
| 12 |
Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: Formation-function-future[J]. Int J Mol Sci, 2016, 17(12): 2028.
|
| 13 |
Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications[J]. Mol Cancer, 2018, 17(1): 147.
|
| 14 |
Coughlan C, Bruce KD, Burgy O, et al. Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses[J]. Curr Protoc Cell Biol, 2020, 88(1): e110.
|
| 15 |
Shirejini SZ, Inci F. The Yin and Yang of exosome isolation methods：conventional practice, microfluidics, and commercial kits[J]. Biotechnol Adv, 2022, 54: 107814.
|
| 16 |
Lin S, Yu Z, Chen D, et al. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications[J]. Small, 2020, 16(9): e1903916.
|
| 17 |
刘 亮，肖 瑶，张 驰. miRNA检测方法的研究进展[J]. 药物分析杂志，2020, 40(1): 70-82.
|
| 18 |
Hu T, Chitnis N, Monos D, et al. Next-generation sequencing technologies：An overview[J]. Hum Immunol, 2021, 82(11): 801-811.
|
| 19 |
Zheng D, Zhu Y, Zhang J, et al. Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules[J]. J Nanobiotechnol, 2022, 20(1): 172.
|
| 20 |
Yang G, Wang T, Qu X, et al. Exosomal miR-21/Let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases[J]. Asia Pac J Clin Oncol, 2020, 16(4): 280-286.
|
| 21 |
Zhou X, Wen W, Shan X, et al. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis[J]. Oncotarget, 2017, 8(4): 6513-6525.
|
| 22 |
Jin X, Chen Y, Chen H, et al. Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing[J]. Clin Cancer Res, 2017, 23(17): 5311-5319.
|
| 23 |
Cazzoli R, Buttitta F, Di Nicola M, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer[J]. J Thorac Oncol, 2013, 8(9): 1156-1162.
|
| 24 |
Zhao Z, Liu J, Wang C, et al. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2[J]. Int J Clin Exp Pathol, 2014, 7(11): 7726-7734.
|
| 25 |
Shen J, Liu Z, Todd NW, et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers[J]. BMC Cancer, 2011, 11: 374.
|
| 26 |
Li Xianfeng, Zhang Qinghua, Jin Xiayun, et al. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study[J]. World J Surg Oncol, 2017, 15(1): 107.
|
| 27 |
Xing L, Su J, Guarnera MA, et al. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules[J]. Clin Cancer Res, 2015, 21(2): 484-489.
|
| 28 |
Zhou P, Lu F, Wang J, et al. A portable point-of-care testing system to diagnose lung cancer through the detection of exosomal miRNA in urine and saliva[J]. Chem Commun (Camb), 2020, 56(63): 8968-8971.
|
| 29 |
范卫杰，张 冬. 影像组学及深度学习在肺结节良恶性鉴别诊断中的新理念[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(5): 549-553.
|
| 30 |
杨 丽，钱桂生. 肺结节临床精准诊断的新理念[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(1): 1-5.
|
| 31 |
Piao XM, Jeong P, Kim YH, et al. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria[J]. Int J Cancer, 2019, 144(2): 380-388.
|
| 32 |
Salahandish R, Ghaffarinejad A, Omidinia E, et al. Label-free ultrasensitive detection of breast cancer miRNA-21 biomarker employing electrochemical nano-genosensor based on sandwiched AgNPs in PANI and N-doped graphene[J]. Biosens Bioelectron, 2018, 120: 129-136.
|